Trial Parameters
Condition Cognitive Behavioral Therapy
Sponsor University of Pittsburgh
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2021-08-02
Completion 2027-12-31
Interventions
cognitive behavioral therapy
Brief Summary
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Eligibility Criteria
Inclusion Criteria: * Age 21 years and older * Fluent in English * Diagnosis of cancer and history of treatment with immunotherapy Exclusion Criteria: * Active suicidal ideation, delusions or hallucinations